 We are pleased to invite investors and analysts to participate in our virtual event on Thursday, 20 February 2025, providing an update on Roche’s sequencing by expansion (SBX) technology. 20:30 – 21:30 CET / 19:30 – 20:30 GMT 2:30 – 3:30 pm EST / 11:30 – 12:30 pm PST The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 19:30 CET on the day of the event. > click here Speakers:
Access to virtual event (pre-registration required) Please pre-register for our webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com *privacy notice Best regards, |
| Bruno Eschli Head of Investor Relations | Birgit Masjost Investor Relations Officer |
| | |
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
| | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com | |
get the latest news and updates to your inbox.